NCE Exclusivity

AbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) Pediatric License Agreement

Post author:GHIAA Admin
Post published:September 4, 2024
Post category:

AbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) License Agreement

Post author:GHIAA Admin
Post published:September 4, 2024
Post category:

Gilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement

Post author:GHIAA Admin
Post published:September 28, 2022
Post category:

The development of the MAPGuide^Ⓡ platform and Equitable Access Toolkit was supported by the Wellcome Trust (grant numbers 219632/Z/19/Z, 221648/Z/20/Z and 225262/Z/22/Z).

If you are interested in providing funding or an in-kind contribution to support GHIAA’s continuing equitable access advocacy work and resource development activities, please contact us using the form below.

Global Healthcare Innovation Alliance Accelerator is a 501(c)(3) non-profit recognized by the IRS.